Assessment of Sclerodermoid Chronic Graft-versus-host Disease with Colour Doppler Ultrasound
- PMID: 33475145
- PMCID: PMC9366684
- DOI: 10.2340/00015555-3747
Assessment of Sclerodermoid Chronic Graft-versus-host Disease with Colour Doppler Ultrasound
Abstract
Sclerodermoid chronic graft-versus-host disease (scGVHD) is a severe complication of allogeneic haema-- topoietic stem cell transplantation. The aim of this study was to investigate the usefulness of high-frequency ultrasound of the skin in assessing the inflammatory patterns and prognosis of patients with scGVHD. A prospective study was carried out with patients who developed scGVHD in the period June 2016 to April 2018. Clinical and ultrasound examinations were performed on the first visit and at 6-month follow-up. A total of 24 patients were included in the study. A 6-month follow-up high-frequency ultrasound of the skin was performed on 20 of the 24 patients. Abnormal B-mode findings in high-frequency ultrasound of the skin consisted of hypoechogenic dermis, hypoechogenicity of septa and hyperechogenicity of lobules in hypodermis. No differences were observed in these basal parameters between treatment progressive/non-responding and inactive/responding scGVHD groups of patients. Basal Doppler showing increased vascular flow with a systolic peak ≥10 cm/s and a vascular resistance index ≥ 0.70 was observed only in those patients who developed progressive/non-responding scGVHD (62.5% vs 0% p = 0.006). In conclusion, Doppler ultrasound is a useful tool to assess the inflammatory activity and outcome of scGVHD. These findings could enhance patient management and help to guide treatment decisions.
Keywords: Doppler ultrasound; allogeneic haematopoietic stem cell transplantation; diagnosis; inflammation; sclerodermoid; graft-versus-host disease.
Conflict of interest statement
Figures
References
-
- Lee SJ, Flowers MED. Recognizing and managing chronic graft-versus-host disease. Hematol Am Soc Hematol Educ Program 2008; 1: 134–141. - PubMed
-
- Cowen EW. Graft-vs-host disease. JAMA Dermatol 2016; 152: 356. - PubMed
-
- Jagasia MH, Greinix HT, Arora M, Williams, K, Wolff D, Cowen E, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 2015; 21: 389–401.e1. - PMC - PubMed
-
- Wortsman X. Ultrasound in dermatology: why, how, and when? Semin Ultrasound CT MR 2013; 34: 177–195. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
